Improvement in word-fluency performance in patients with multiple sclerosis by electromagnetic fields

References

• Albert M. L. Subcortical dementia. Alzheimer's disease: senile dementia and related disorders, R. Katzman, R. D. Terry, K. L. Bick. Raven Press, New York 1978; 173–180
   Google Scholar
• Albert M. L., Feldman R., Willis A. L. The subcortical dementia of progressive supranuclear palsy. Journal of Neurology Neurosurgery and Psychiatry 1974; 37: 121–130
   PubMed Web of Science ®Google Scholar
• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Anton‐Tay F. Melatonin: effects on brain function. Advances in Biochemical Psychopharmacology 1974; 11: 315–324
   PubMedGoogle Scholar
• Anton‐Tay F., Diaz J. L., Fernandez‐Guardiola A. On the effects of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Arnett P. A., Rao S. M., Bernardin L., Grafman J., Yetkin F. Z., Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994; 44: 420–425
   PubMed Web of Science ®Google Scholar
• Averbuch‐Heller L., Shalev A. Y., Abramowitz M. Z. An unusual presentation of multiple sclerosis. American Journal of Psychiatry 1992; 149: 410–411
   PubMed Web of Science ®Google Scholar
• Bal M. A. A., Vazquez‐Barquero J. L., Pena C., Miro J., Berciano J. A. Psychiatric aspects of multiple sclerosis. Acta Psychiatrica Scandinavica 1990; 83: 292–296
   Web of Science ®Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Beardsley J. V., Puletti F. Personality (MMPI) and cognitive (WAIS) changes after levodopa treatment. Archives of Neurology 1971; 25: 145–150
   PubMedGoogle Scholar
• Beatty W. W., Goodkin D. E., Monson N., Beatty P. A., Hertsgaard D. Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis. Archives of Neurology 1988; 45: 611–619
   PubMed Web of Science ®Google Scholar
• Beatty W. W., Goodkin D. E., Beatty P. A., Monson N. Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosis. Brain and Cognition 1989; II: 73–86
   Google Scholar
• Benton A. L. Differential effects of frontal lobe disease. Neuropsychologia 1968; 6: 53–60
   Web of Science ®Google Scholar
• Bergin J. D. Rapidly progressing dementia in disseminated sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1957; 20: 285–292
   PubMed Web of Science ®Google Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the mid‐brain can regulate dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
   Google Scholar
• Brozoski T. J., Brown R. M., Rosvold H. E., Goldman P. S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205: 929–932
   PubMed Web of Science ®Google Scholar
• Bubenik G. A., Brown G. M., Grota J. L. Differential localization of N‐acetyled indolalkylamines in CNS and the Harderian gland using immunohistology. Brain Research 1976; 118: 417–427
   PubMed Web of Science ®Google Scholar
• Burton S., Daya S., Potgieter B. Melatonin modulates apomorphine‐induced rotational behaviour. Experientia 1991; 47: 46–69
   Google Scholar
• Caine E. D., Bamford H. A., Schiffer R. B., Shoulson I., Levy S. A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis. Archives of Neurology 1986; 43: 249–254
   PubMed Web of Science ®Google Scholar
• Cardinali D. P., Vacas M. I., Estevez‐Boyer E. Specific binding for melatonin in bovine brain. Endocrinology 1979; 105: 437–441
   PubMed Web of Science ®Google Scholar
• Charcot J. M. Lectures on the diseases of the nervous system delivered at la salpetriere, G. Sigerson. The New Sydenham Society, London 1877; 194–195
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Comings D. E. Tourette syndrome and human behavior. Hope Press, Duarte, CA 1990; 341–361
   Google Scholar
• Comings D. E., Benson D. F. Subcortical dementia. Archives of Neurology 1986; 41: 874–879
   Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movement induced by L‐dopa in mice. Science 1971; 173: 450–452
   PubMed Web of Science ®Google Scholar
• Datta P. C., King M. G. Melatonin: effects on brain and behavior. Neuroscience & Biobehavioral Reviews 1980; 4: 451–458
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates C. M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology. Neurosurgery, and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Demaine C., Semm P. The avian pineal gland as an independent magnetic sensor. Neuroscience Letters 1985; 62: 119–122
   PubMed Web of Science ®Google Scholar
• Descarries L., Beaudet A., Watkins K. C. Serotonin nerve terminal in adult rat neocortex. Bruin Research 1975; 100: 563–588
   PubMed Web of Science ®Google Scholar
• Dixey R., Rein G. (3H) Noradrenaline release potentiated in a clonal cell line by low intensity pulsed magnetic fields. Nature 1982; 206: 253–256
   Google Scholar
• Filley C. M., Heaton R. K., Nelson L. M., Burks J. S., Franklin G. M. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Archives of Neurology 1989; 46: 157–161
   PubMedGoogle Scholar
• Flax J. W., Gray J., Herbert J. Effect of fluoxetine on patients with multiple sclerosis. American Journal of Psychiatry 1991; 148: 1603
   PubMed Web of Science ®Google Scholar
• Franklin G. M., Nelson L. M., Filley C. M., Heaton R. K. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology 1989; 46: 162–167
   PubMed Web of Science ®Google Scholar
• Gaffori O., Van Ree J. M. Serotonin and antidepressant drugs antagonize melatonin‐induced behavioural changes after injection into the nucleus accumbens of rats. Neuropharmacology 1985; 24: 237–244
   PubMed Web of Science ®Google Scholar
• Cowers W. R. A manual of diseases of the nervous system2nd Edition. Churchill, London 1893
   Google Scholar
• Grant I., McDonald W. I., Trimble M. R., Smith E., Reed R. Deficient learning and memory in early and middle phases of multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1984; 47: 250–255
   PubMed Web of Science ®Google Scholar
• Harrer G., Fischbach R. Uber die wirkung bestimmter aminosauren auf das ergebniss des unberwarmungstests bein multiple sclerose kranken. Journal of Neural Transmission 1973; 34: 205–214
   PubMed Web of Science ®Google Scholar
• Heaton R. K., Nelson L. M., Thompson D. S., Burks J. S., Franklin G. M. Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis. Journal of Consulting and Clinical Psychology 1985; 53: 103–110
   PubMed Web of Science ®Google Scholar
• Honer W. G., Hurwitz T., Li D. K. B., Palmer M., Paty D. W. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Archives of Neurology 1987; 44: 187–190
   PubMedGoogle Scholar
• Hyyppa M. T., Falck S. C. L‐tryptophan and neuroendocrine regulation in neurologic patients: gonadotrophin secretion, sexual motivation and responsiveness during L‐tryptophan treatment in patients with multiple sclerosis. Psychoneuroendocrinology 1977; 2: 359–363
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rinne U. K. Effects of L‐tryptophan on central indoleaminemetabolism and short‐lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Jaffe R. A., Laszewski B. L., Car D. B., Phillips R. D. Chronic exposure to a 60‐Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectromagnetics 1980; 1: 131–147
   PubMedGoogle Scholar
• Jambor K. L. Cognitive functioning in multiple sclerosis. British Journal of Psychiatry 1969; 115: 765–775
   PubMed Web of Science ®Google Scholar
• Javoy‐Agid F., Agid Y. Is the mesocortical dopaminergic system involved in Parkinson's disease?. Neurology 1980; 30: 1326–1330
   PubMed Web of Science ®Google Scholar
• Johansson B., Ross B. E. 5‐hydroxyindoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology 1977; 11: 37–45
   Web of Science ®Google Scholar
• Kahana E., Leibowitz U., Alter M. Cerebral multiple sclerosis. Neurology 1971; 21: 1179–1185
   PubMed Web of Science ®Google Scholar
• Kaplan E. The process approach to neuropsychological assessment of psychiatric patients. Journal of Neuropsychiatry 1990; 2: 72–87
   PubMedGoogle Scholar
• Kolb B., Whishaw I. Q. Fundamentals of human neuropsychology. W. H. Freeman and Company, New York 1990; 455–456; 233–236; 463–501
   Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• Lennon V. A., Carnegie P. R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet 1971; 2: 630–633
   Google Scholar
• Lezak M. D. Neuropsychological assessmentsecond Edition. Oxford University Press, New York 1983; 68–69; 382–413
   Google Scholar
• Lindvall O., Bjorklund A., Moore R. Y., Stenevi U. Mesencephalic dopamine neurons projecting to neocortex. Brain Research 1974; 81: 325–331
   PubMed Web of Science ®Google Scholar
• Loranger A. W., Goodell H., McDowell F. H., Lee J. E., Sweet R. D. Intellectual impairment in Parkinson's disease. Brain 1972; 95: 405–412
   PubMed Web of Science ®Google Scholar
• Luga N., Hategan D. Determination of serotonin content and ceruloplasmin activity of blood and CSF amino acid level in multiple sclerosis. Review Roumanian Medicine‐ Neurology and Psychiatry 1986; 24: 153–159
   Google Scholar
• Lumsden C. E. The neuropathology of multiple sclerosis. Handbook of clinical neurology, P. J. Vinken, G. W. Bruyn. North Holland, Amsterdam 1970; vol. 9: 217–309
   Google Scholar
• Markianos M., Sfagos C. Altered serotonin uptake kinetics in multiple sclerosis. Journal of Neurology 1988; 235: 236–237
   PubMed Web of Science ®Google Scholar
• Mesulam M. M. Frontal cortex and behavior. Annals of Neurology 1986; 19: 320–325
   PubMed Web of Science ®Google Scholar
• Milner B. Some effects of frontal lobectomy in man. The frontal granular cortex und behavior, J. M. Warren, K. Akert. McGraw‐Hill, New York 1964; 313–334
   Google Scholar
• Milner B., Petrides M. Behavioural effects of frontal lobe lesions in man. Trends in Neurosciences 1984; 7: 403–407
   Web of Science ®Google Scholar
• Minden S., Schiffer R. B. Affective disorders in multiple sclerosis: review and recommendations for clinical research. Archives of Neurology 1990; 47: 98–104
   PubMed Web of Science ®Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 640–641
   PubMed Web of Science ®Google Scholar
• Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. European Journal of Pharmacology 1973; 55: 219–220
   Web of Science ®Google Scholar
• Olcese J., Reuss S., Semm P. Geomagnetic field detection in rodents. Life Sciences 1988; 42: 605–613
   PubMed Web of Science ®Google Scholar
• Osterrieth P. A. Le test de copie d'une figure complexe. Archives of Psychology 1944; 30: 206–356
   Google Scholar
• Parsons O. A., Stewart K. D., Arenberg D. Impairment of abstracting ability in multiple sclerosis. Journal of Nervous and Mental Disease 1957; 125: 22–225
   Web of Science ®Google Scholar
• Pazo J. H. Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin 1979; 4: 727–730
   Web of Science ®Google Scholar
• Pazos A., Cones R., Palacios J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain, II. serotonin‐2‐receptors. Brain Research 1985; 346: 231–249
   PubMed Web of Science ®Google Scholar
• Peyser J. M., Rao S. M., LaRocca N. G., Kaplan E. Guidelines for neuropsychological research in multiple sclerosis. Archives of Neurology 1990; 47: 94–97
   PubMed Web of Science ®Google Scholar
• Rabins P. V., Brooks B. R., O'Donnell P., Pearlson G. D., Moberg P., Jubelt P., Coyle P., Dalos N., Folstein M. F. Structural brain correlates of emotional disorder in multiple sclerosis. Brain 1986; 109: 585–597
   PubMed Web of Science ®Google Scholar
• Ramier A. M., Hecan H. Role respectif des atteintes frontales et de la lateralisation lesionnelle dans les deficits de la “fluence verbale.”. Revue de Neurologie 1970; 123: 17–22
   PubMed Web of Science ®Google Scholar
• Rao S. M. Neuropsychology of multiple sclerosis: a critical review. Journal of Clinical and Experimental Neuropsychology 1986; 8: 503–542
   PubMed Web of Science ®Google Scholar
• Rao S. M., Hammeke T. A. Hypothesis testing in patients with chronic progressive multiple sclerosis. Brain and Cognition 1984; 3: 94–104
   PubMed Web of Science ®Google Scholar
• Rao S. M., Hammeke T. A., McQuillen M. P., Khatri B. O., Lloyd D. Memory distrubance in chronic progressive multiple sclerosis. Archives fo Neurology 1984; 41: 625–431
   PubMed Web of Science ®Google Scholar
• Rao S. M., Glatt S., Hammeke T. A. Chronic progressive multiple sclerosis: relationship between cerebral ventricular size and neuropsychological impairment. Archives of Neurology 1985; 42: 678–682
   PubMed Web of Science ®Google Scholar
• Rao S. M., Hammeke T. A., Speech T. J. Wisconsin Card Sorting Test performance in relapsing‐remitting and chronic progressive multiple sclerosis. Journal of Consulting and Clinical Psychology 1987; 55: 263–265
   PubMed Web of Science ®Google Scholar
• Rao S. M., Leo G. J., Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991a; 41: 685–691
   PubMed Web of Science ®Google Scholar
• Rao S. M., Leo G. J., Ellington L., Nauertz T., Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991b; 41: 692–696
   PubMed Web of Science ®Google Scholar
• Rao S. M., Huber S. J., Bernstein R. A. Emotional changes with multiple sclerosis and Parkinson's disease. Journal of Consulting and Clinical Psychology 1992; 60: 369–378
   PubMed Web of Science ®Google Scholar
• Rascol A., Clanet M., Montastruc J. L., Delage W., Guiraud‐Chaumeil B. L‐5‐hydroxytrophan in the cerebelalr syndrome treatment. Biomedicine 1991; 35: 112–113
   Google Scholar
• Reader T. A. Distribution of catecholamines and serotonin in the rat cerebral cortex: absolute levels and relative proportions. Journal of Neural Transmission 1981; 50: 13–27
   PubMed Web of Science ®Google Scholar
• Reading P. J. Frontal lobe dysfunction in schizophrenia and Parkinson's disease‐ a meeting point for neurology, psychology and psychiatry: discussion paper. Journal of the Royal Society of Medicine 1991; 84: 349–353
   PubMed Web of Science ®Google Scholar
• Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Archives of Psychology 1942; 28: 286–340
   Google Scholar
• Rosen A. D. Magnetic field influence on acetylcholine release at the neuromuscular junction. American Journal of Physiology 1992; 262: C1418–C1422, (cell physiol,31)
   PubMed Web of Science ®Google Scholar
• Rusovan A., Kanje M. D600, a Ca2+ antagonist, prevents stimulation of nerve regeneration by magnetic fields. NeuroReport 1992; 3: 813–814
   PubMed Web of Science ®Google Scholar
• Sallanon M., Claustrat B., Touret M. Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica 1982; 101: 161–165
   PubMedGoogle Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992a; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields as a novel therapeutic modality in Parkinson's disease. International Journal of Neuroscience 1992b; 66: 1–15
   PubMed Web of Science ®Google Scholar
• Sandyk R. Magnetic fields in the therapy of parkinsonism. International Journal of Neuroscience 1992c; 66: 209–235
   PubMed Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience 1993; 72: 141–148
   PubMedGoogle Scholar
• Sandyk R. Improvement in word‐ fluency performance in Parkinson's disease by administration of electromagnetic Fields. International Journal of Neuroscience 1994; 77: 23–46
   PubMedGoogle Scholar
• Sandyk R. Further observations on the effects of external picotesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis. International Journal of Neurocience
   Web of Science ®Google Scholar
• Sandyk R., Fisher H. Increased incidence of neuroleptic‐induced movement disorders in pinealectomized rats. International Journal of Neuroscience 1989; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993a; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience 1993b; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Further observations on the unique efficacy of picotesla magnetic fields in Parkinson's disease. International Journal of Neuroscience 1993c; 69: 167–183
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. The effects of picotesla range magnetic fields on visuospatial functions in multiple sclerosis. International Journal of Neuroscience
   Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields. International Journal of Neuroscience 1994; 74: 177–189
   PubMedGoogle Scholar
• Sandyk R., lacono R. P. Improvement by picotesla range magnetic fields of perceptual‐motor performance and visual memory in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience
   Web of Science ®Google Scholar
• Scatton B., Rouquier L., Javoy‐Agid F., Agid Y. Dopamine deficiency in the cerebral cortex in Parkinson disease. Neurology 1982; 32: 1039–1040
   PubMed Web of Science ®Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–489
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth‐strengh magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore‐Ede, S. S. Campbell, R. J. Reiter. Birkhäuser, Boston 1992; 53–62
   Google Scholar
• Semm P., Schneider T., Vollrath L. Effects of an earth‐strengh magnetic field on electrical activity of pineal cells. Nature 1980; 288: 607–408
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Stankov B., Fraschini F., Reiter R. J. Melatonin binding sites in the central nervous system. Brain Research Reviews 1991; 16: 245–256
   PubMedGoogle Scholar
• Staples D., Lincoln N. B. Intellectual impairment in multiple sclerosis. Rheumatology & Rehabilitation 1979; 18: 153–160
   PubMedGoogle Scholar
• Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry 1969; 115: 749–764
   PubMed Web of Science ®Google Scholar
• Tabaddor K., Wolfson L. I., Sharpless N. S. Ventricular fluid homovanillic acid and 5‐hydroxyindoleacetic acid concentrations in patients with movement disorders. Neurology 1978; 28: 1249–1253
   PubMed Web of Science ®Google Scholar
• Taff I., Sabato U. C., Lehrer G. Choreoathetosis in multiple sclerosis. Clinical Neurology and Neurosurgery 1985; 87: 41–43
   PubMed Web of Science ®Google Scholar
• Taylor E. M. The appraisal of children with cerebral deficits. Harvard University Press, Cambridge, Mass 1959
   Google Scholar
• Taylor L. B. Localization of cerebral lesions by psychological testing. Clinical Neurosurgery 1969; 16: 269–287
   PubMedGoogle Scholar
• Trimble M. R., Zarifian E. Psychopharmacology of the limbic system. Oxford Medical Publication, Oxford 1985; 118–120
   Google Scholar
• Trouillas P., Brudon F., Adeleine P. Improvement of cerebellar ataxia with levorotatory form of 5‐hydroxytryptophan. Archives of Neurology 1988; 45: 1217–1222
   PubMed Web of Science ®Google Scholar
• Uhi G. R., Hedreen J. C., Price D. L. Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions. Neurology 1985; 35: 1215–1218
   PubMed Web of Science ®Google Scholar
• Vacas M. I., Cardinali D. P. Diurnal changes in melatonin binding sites of hamster and rat brains. Correlation with neuroendocrine responsiveness to melatonin. Neuroscience Letters 1979; 15: 259–263
   PubMed Web of Science ®Google Scholar
• Vitte P. A., Harthe C., Pevet P., Claustrat B. Brain autoradiographic study in the golden hamster after intracarotid injection of ‘14T’ melatonin. Neuroscience Letters 1990; 110: 1–5
   PubMed Web of Science ®Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N‐acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Weinberger D. R. Schizophrenia and the frontal lobe. Trends in Neuroscience 1988; 11: 367–370
   PubMed Web of Science ®Google Scholar
• White R. F. Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry 1990; 2: 422–428
   PubMedGoogle Scholar
• Williams L. M., Morgan P. J., Hatings M. H., Lawson W., Davidson G., Howell H. E. Melatonin receptors sites in the Syrian hamster brain and pituitary. Localization and characterization using ‘125I’ iodomelatonin. Journal of Neuroendocrinology 1989; 1: 315–320
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Anderson L. E., Hilton D. I., Phillips R. D. Chronic exposure to 60‐Hz electric field effects on pineal function in the rat. Bioelectromagnetics 1981; 2: 371–380
   PubMed Web of Science ®Google Scholar
• Wood F. B., Ebert V., Kinsbourne M. The episodic‐semantic memory distinction in memory and amnesia clinical and experimental observations. Human memory and amnesia, L. Cermak. Lawrence Erlbaum Associates, Hillsdale, NJ 1982; 167
   Google Scholar
• Young A. C., Saunders J., Ponsford J. R. Mental change as an early feature of multiple sclerosis. Journal (of Neurology Neurosurgery and Psychiatry 1976; 39: 1008–1013
   PubMed Web of Science ®Google Scholar
• Zangwill O. L. Psychological deficits associated with frontal lobe lesions. International Journal of Neurology 1966; 5: 395–402
   Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: regional distribution in the rat brain. Bruin Research 1982; 246: 161–163
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus in vitro: variations with sex and the estrous cycle. Neuroendocrinology 1983; 37: 41–47
   PubMed Web of Science ®Google Scholar